Analyst Reco. Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse Other stock markets 21:00:02 13/09/2024 BST			5-day change	1st Jan Change
923.71 ^USD	-1.21%		+2.33%	+58.46%

09-13	Eli Lilly Gets FDA Approval for Eczema Treatment Ebglyss	DJ
09-13	Eli Lilly Gets US FDA Approval for Atopic Dermatitis Treatment	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Raises Price Target on Eli Lilly to $1,100 From $1,050	09-13	MT
Jefferies Adjusts Price Target on Eli Lilly to $1,113 From $1,050	08-27	MT
Global markets live: Novo Nordisk, Walmart, Target, Keysight Technologies, Coty...	08-21
Eli Lilly: risk of diabetes reduced by 94% with tirzepatide	08-20	CF
HSBC Adjusts Price Target on Eli Lilly and Co. to $1,150 From $1,100, Maintains Buy Rating	08-15	MT
ELI LILLY : Berenberg raises its price target	08-14	CF
Eli Lilly: share price rises, Berenberg raises target	08-14	CF
Daiwa Securities Adjusts Price Target on Eli Lilly and Co. to $940 From $800, Maintains Outperform Rating	08-14	MT
Berenberg Adjusts Price Target on Eli Lilly and Co. to $1,050 From $1,000, Maintains Buy Rating	08-14	MT
Deutsche Bank Upgrades Eli Lilly to Buy From Hold, Raises Price Target to $1,025 From $725	08-12	MT
Analyst recommendations: Biogen, Cloudflare, Doordash, Moderna, Diageo...	08-12
Redburn Atlantic Adjusts Eli Lilly Price Target to $640 From $600	08-09	MT
Wells Fargo Adjusts Price Target on Eli Lilly to $1,000 From $875, Maintains Overweight Rating	08-09	MT
JPMorgan Adjusts Price Target on Eli Lilly and Company to $1,050 From $1,000, Maintains Overweight Rating	08-09	MT
BMO Capital Adjusts Price Target on Eli Lilly to $1,101 From $1,001, Maintains Outperform Rating	08-09	MT
Leerink Partners Adjusts Eli Lilly Price Target to $990 From $901	08-09	MT
Morgan Stanley Raises Price Target on Eli Lilly to $1,106 From $1,083, Adds 'Top Pick' Label, Keeps Overweight Rating	08-09	MT
Guggenheim Adjusts Price Target on Eli Lilly to $884 From $855	08-05	MT
Wolfe Research Adjusts Eli Lilly's Price Target to $1,117 From $909	07-24	MT
Analyst recommendations: Colgate, Lockheed Martin, Procter & Gamble, Eli Lilly, Tesla...	07-24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 06:47 pm